As I returned home from my first visit to ASH, I was still at a loss for words for what I witnessed while at the conference. The hype that I had when anticipating getting there lived up to my expectations. It took me a while to grasp the concept of the Abstracts. Once I got […]
ASH 2016: Patient Perspective with Thomas Goode
When Thomas Goode arrived at the 58th American Society of Hematology annual meeting, he felt “mesmerized” and was not sure “how he would accept it all.” He leaves realizing that he is now, not just a myeloma patient, but an active advocate armed with information. Near the end of this video, he expresses his gratitude […]
#ASH16: I have arrived
After two horrible flights to get here that warranted both airplanes needing maintenance, I was completely worn out when I arrived in San Diego. I was hoping that this was not going to be a sign that I was going to have a horrible experience. After greeting the rest of our team at breakfast, I […]
My first visit to ASH
In 2005, I was diagnosed with this dreaded disease. As I look back over my journey since I’ve been diagnosed with multiple myeloma, the one thing that came to mind was the fact that the average life span for newly diagnosed patients was three to five years. As I began treatment, I did not know […]
Thomas Goode
Diagnosed with myeloma in 2005, Thomas Goode today co-leads the Triangle Area Support Group in North Carolina and is also a Reflective Ambassador for Celgene. The IMF welcomes Thomas to his first ASH Annual Meeting.
Follow Thomas on Twitter